CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31

Cannabis Bioscience International Holdings, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026

$0.00+0.00 (+33.33%)

Close on Oct 19, 2026

Community

Notes and questions about Cannabis Bioscience International from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Cannabis Bioscience International's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 28, 2009
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CBIH.

Revenue growth-64.1% · median -62.3%

Gross margin78.8% · median -83.4%

Operating margin-322.6% · median -2020.0%

Net margin-416.8% · median -2449.0%

Advertisement
300 × 250